Market Cap (In USD)
5452.00
Revenue (In USD)
-
Net Income (In USD)
-39.76 Million
Avg. Volume
197.55 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-4-0.2725
- PE
- -
- EPS
- -
- Beta Value
- 1.894
- ISIN
- US08773T1043
- CUSIP
- 08773T104
- CIK
- 1832415
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Frank L. Karbe
- Employee Count
- -
- Website
- https://www.bettertx.com
- Ipo Date
- 2021-03-17
- Details
- Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
More Stocks
-
9022
-
BLHEFBâloise Holding AG
BLHEF
-
VGOVIGO System S.A.
VGO
-
6720
-
SISXFSavaria Corporation
SISXF
-
2388
-
AGHOL
-
4980